Total planned funding: $308,081,634
Allocations
Countries/Regions
| Eswatini | $308,081,634 |
Organizational Types
| Private Contractor | $72,678,554 |
| Unknown | $62,999,802 |
| University | $57,268,870 |
| NGO | $50,540,287 |
| Own Agency | $37,636,405 |
| Host Country Government Agency | $10,375,079 |
| FBO | $7,784,055 |
| Multi-lateral Agency | $7,232,970 |
| Other USG Agency | $975,612 |
| Implementing Agency | $590,000 |
Program Areas
| Care | $95,520,161 |
| Treatment | $78,105,032 |
| Prevention | $59,400,393 |
| Governance and Systems | $32,455,195 |
| Management and Operations | $23,852,642 |
| Testing | $18,748,211 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $61,517,705 |
| HBHC: Care: Adult Care and Support | $38,242,696 |
| HKID: Care: Orphans and Vulnerable Children | $32,230,151 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $24,348,766 |
| HVMS: Management and Operations | $23,852,642 |
| HVCT: Testing: HIV Testing and Counseling | $18,748,211 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,320,167 |
| HVTB: Care: TB/HIV | $16,283,764 |
| OHSS: Health Systems Strengthening | $13,566,729 |
| HVSI: Strategic Information | $13,044,094 |
| HTXD: Treatment: ARV Drugs | $8,765,679 |
| PDCS: Care: Pediatric Care and Support | $8,763,550 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,736,922 |
| PDTX: Treatment: Pediatric Treatment | $7,821,648 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,477,567 |
| HLAB: Laboratory Infrastructure | $5,844,372 |
| HMBL: Biomedical Prevention: Blood Safety | $1,516,971 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Columbia University:
$51,827,638
Countries/Regions
Not Available:
$49,088,922
Countries/Regions
Pact, Inc.:
$35,892,415
Countries/Regions
USG Aggregated Agencies:
$22,347,690
Countries/Regions